Jared Kaltwasser

New research shows people with psychogenic nonepileptic seizures (PNES) have higher rates of childhood trauma of all types compared with people with epilepsy.

The study offers guidance to clinicians treating the roughly 10% of patients with rare EGFR mutations.

The new report is based on real-world data from a patient registry and shows some patients even regain motor function under treatment with nusinersen for spinal muscular atrophy (SMA).

The use of continuous glucose monitoring and attendance at a diabetes education appointment appeared to increase the odds of patient improvement.

The study of real-world evidence (RWE) found nearly 9 in 10 patients in a highly vaccinated cohort avoided hospitalization within 15 days of treatment for COVID-19.

A new report highlights the role at-home care played for geriatric patients during the COVID-19 pandemic.

The study findings suggest that eosinophilic esophagitis (EoE), like other atopic diseases, may be associated with infections.

Investigators still do not fully understand how cannabidiol (CBD) works in patients with seizures, according to a new review.

New data show patients treated with chimeric antigen receptor (CAR) T-cell therapy as salvage therapy tended to have meaningful results despite treatment failure following B-cell maturation antigen (BCMA) CAR T.

Patient avoidance or postponement of care are common reasons for home health care delays, the authors said.

Authors also found that the mortality rate of people with cutaneous lupus erythematosus (CLE) are generally similar to that of the general population.

The child living with spinal muscular atrophy (SMA) type 2 had less fatigue and improved functional scores as time went on.

These second-generation basal insulin analogs, Gla-300 and IDeg-100, also had similar safety profiles, investigators found.

This new study shows how using electronic health record (EHR) data can objectively quantify patient treatment burden among individuals who have multiple myeloma (MM) compared with patient-reported outcomes, which can be subject to recall bias.

Lung cancer is the number one cause of cancer-related deaths among women in the United States, yet relatively little research funding is spent on the issue, the authors of a new study say.

This new report also shows the value of national databases tracking the use of ventilation support.

A new report has found continuous glucose monitoring (CGM) may help reduce staff burden in the intensive care unit (ICU) by reducing the need for blood gas monitoring.

The new data suggest risdiplam can be a viable option for people with spinal muscular atrophy who cannot take or tolerate the 2 other approved disease-modifying therapies.

A new report underscores how treatment decisions for non-small cell lung cancer (NSCLC) affect patients’ health care utilization and costs.

Colombia and Brazil had the highest prevalence and incidence of systemic lupus erythematosus (SLE), a new investigation found.

A new report found interesting links between genetic factors associated with COVID-19 severity and autoimmune disease among persons who have systemic lupus erythematosus (SLE).

Existing evidence suggests genetics, environmental factors, and exposure to specific chemicals—such as those in cigarettes—can all increase a person’s risk of systemic lupus erythematosus.

It is unclear what role treatment plays in affecting hepatocellular carcinoma (HCC) risk, the authors found.

These new study data are based on 20 years of follow-up in 92 Chinese children with lupus nephritis.

Intrahepatic and perihilar cholangiocarcinoma, in particular, grew faster in young patients than in older patients.

It is not yet clear what continuous glucose monitoring metrics should be used for a diabetes diagnosis in people with cystic fibrosis.

Blacks and Hispanics with systemic lupus erythematosus (SLE) are more than twice as likely to have severe outcomes from COVID-19 compared with White patients with SLE, a new study has found.

The index for eosinophilic esophagitis (EoE) was crafted based on a literature review by a multidisciplinary team of experts.

Data suggest incidence and prevalence of systemic lupus erythematosus (SLE) vary widely among regions, although the authors noted some regions have been studied more extensively than others.